Dairy and soy free, non GMO healthy bacteria that survive and thrive
Dairy and soy free, non GMOhealthy bacteria that survive and thrive
By Jerry Hickey, R.Ph Follow on Google+
Fermented milks have been a part of the human diet since ancient times. Their ability to calm digestive disorders has been exploited in systems of traditional medicine the world over. Lactic acid bacteria, the microbial flora in fermented milks are also the natural inhabitants of the human intestinal tract. They are thought to be responsible for the longevity of their hosts through their curative and preventative actions.
The role of lactic acid bacteria in gastrointestinal microecology is currently the subject of extensive research worldwide. It is widely believed that these bacteria prevent the growth of putrefactive microorganisms responsible for ill health via competitive inhibition (crowding them out), and by their ability to generate an environment hostile to infectious organisms. They produce acids such as lactic and butyric acids that provide energy for digestion and for intestinal immunity. They also form antibiotic-like substances (bacteriocins) that keep the growth of infectious organisms in check.
Humans have about two pounds of bacteria in the intestines. Probiotic refers to the lactic acid producing strains required for overall health and digestion. The pressures of modern existence make it difficult to maintain a balanced population of normal, healthy microbes. Poor food choices, illness, intestinal inflammation, toxins, even weight gain can cause a tipping point allowing the overgrowth of dangerous species.
The logical approach to restoring the balance of intestinal flora is the use of probiotics. However, reports on the survival and effectiveness of these microorganisms in the gastrointestinal tract are controversial. Ingested as viable organisms, these microbes often do not survive the rigors of the gastric environment.
The InVite Health scientific team has solved this, providing strains of healthy bacteria that survive and thrive. The five strains utilized, have been proven in human clinical trials to colonize, and have also been proven to offer a range of benefits for general health and for the digestive tract.
LactoSpore® is a lactic acid producing bacterial strain from Sabinsa Corporation. This species forms spores, which on activation in the acidic environment of the stomach, can germinate and proliferate in the intestine, produce the favored L form of lactic acid and effectively compete with the problematic bacteria. LactoSpore® has been used in successful clinical trials. A colony forming unit (CFU) represents the number of viable bacterial cells that can colonize and act as progenitors that multiply into many additional flora. 600,000 CFU of LactoSpore is intestinal health insurance. The four additional strains are supplied as two-billion CFU each.
The four additional species have all shown ability to sustain or restore health being especially effective for good digestion according to the results of human clinical trials. They improve bloating, flatulence, occasional gastric distress, nausea, vomiting, diarrhea, and constipation. They are not spore forming bacteria; technology ensures their survival. Pharmachem Laboratories microencapsulation technology uses a lipid system that coats the probiotic powder. The bacteria are released in the lower gastrointestinal tract alive, uninjured and viable.